IFA Anti-Doping Rules
Regarding to the World Anti-Doping Code (valid from 1.1.2015) the IFA Executive Board adopted the “IFA Anti-Doping Rules based on Wada’s Models of Best Practice for IFA Anti Doping Rules WADA_ valid from 1 January 2015 These Anti-Doping Rules apply to IFA and to each of its National Federations. They also apply to all Athletes, Athlete Support Personnel and other Persons, each of whom is deemed, as a condition of his/her membership, accreditation and/or participation in the sport, to have agreed to
be bound by these Anti-Doping Rules, and to have submitted to the authority of IFA to enforce these Anti-Doping Rules and to the jurisdiction of the hearing panels specified in Article 8 and Article 13 to hear and determine cases and appeals brought under these Anti-Doping Rules. Details can be found in the document.

List of Prohibited Substances and Methods
The 2020 List of Prohibited Substances and Methods can be found here. The List, which is updated annually, comes into force on 1st January 2020. A summary of major modifications and explanatory notes can be found here.

The 2019 List of Prohibited Substances and Methods, the 2018 List of Prohibited Substances and Methods , the 2017 List of Prohibited Substances and Methods can be found here.

IFA Test Distribution Plan (TDP)
IFA is doing Out-of-Competition testing (OOCT) as urine test and blood test as well as In-Competition testing (ICT).

IFA Testing Pool
Regarding to the IFA Anti-Doping regulation Article 5.6.6. IFA has established an IFA Anti-Doping Testing Pool.

IFA Annual Statistical Anti-Doping Report
As per Art. 14.4 of the World Anti-Doping Code IFA provides an annual statistical Anti-Doping report.
IFA Anti Doping Report 2018

World Anti-Doping Code
The World Anti-Doping Code can be found here.

WADA International Standards
The WADA International Standards can be found here.
These include the following Standards: Prohibited List, Testing, Therapeutic Use Exemptions, Laboratories, Protection of Privacy and Personal information.

Therapeutic Use Exemptions (TUE)
Athlete to complete sections 1, 5, 6 and 7; physician to complete sections 2, 3 and 4. THERAPEUTIC USE EXEMPTION (TUE) APPLICATION FORM

As an IFA automatically recognizes TUE decisions of other Anti-Doping Organizations.
you will automatically recognize
or MEO, do you publish a notice (at a minimum, by posting it in a conspicuous place on your website and sending it to WADA) that sets out clearly
(1) which Athletes coming under your jurisdiction are required to apply to you for a TUE, and when;
(2) which TUE decisions of other Anti-Doping Organizations you will automatically recognize in lieu of such application, in accordance with Article 7.1(a); and
(3) which TUE decisions of other Anti-Doping Organizations will have to be submitted to you for recognition, in accordance with Article 7.1(b) ?

Athletes, like all people, may have illnesses or conditions that require them to take particular medications or undergo procedures. If the medication or method an athlete is required to take/use to treat an illness or condition is included in the World Anti-Doping Agency’s (WADA) Prohibited List, a Therapeutic Use Exemption (TUE) may give that athlete the authorization to take a substance or use a method that is prohibited.

Applications for TUEs are reviewed by a panel of experts, the TUE Committee (TUEC) who may give such permission.

All of the four following criteria must be met (for more details, please refer to the WADA International Standard for Therapeutic Use Exemptions (ISTUE) Article 4.1):

– The athlete has a clear diagnosed medical condition which requires treatment using a prohibited substance or method;
– The therapeutic use of the substance would not produce significant enhancement of performance beyond the athlete’s normal state of health;
– There is no reasonable therapeutic alternative to the use of the prohibited substance or method;
– The necessity to use that substance or method is not a consequence of the prior use (without a TUE), of a substance or method which was prohibited at the time of use.

First, check if the required medication or method you intend to take or use appears on the Prohibited List.

You have the responsibility to inform your doctors that you are an athlete subject to doping control, and your doctors should check the Prohibited List whenever they prescribe a medication / method to you. If the substance / method is prohibited, check with your doctors if there are any alternative treatments that are not prohibited. If not, you have to apply for a TUE.

Second, check your competition level to determine to which organization, and when to apply for a TUE.

==> If you are an International-Level Athlete [Insert the IF’s definition of International-Level Athletes] you must apply to IFA in advance, as soon as the need arises, unless there are emergency or exceptional circumstances.

For substances prohibited in-competition only, you should apply for a TUE at least 30 days before your next competition.
Please refer to the section “How to apply to IFA for a TUE?” below.

If you already have a TUE granted by your National Anti-Doping Organization (NADO):

Automatic recognition:

IFA automatically recognizes that TUE. Please notify IFA that you have a TUE granted by your NADO.

==> If you are NOT an International-Level Athlete and you have been tested by IFA, IFA recognizes a valid TUE granted by your NADO (i.e., it satisfies the ISTUE criteria for granting a TUE). If, moreover, you are also NOT a National-Level Athlete as defined by your NADO and you have been tested by IFA, you must apply for a retroactive TUE to IFA.

You may only apply retroactively for a TUE to IFA if:

– Your competition level permits (i.e., you are not an International-Level Athlete as defined by IFA nor a National-Level Athlete as defined by your NADO; or
– An emergency or urgent treatment of a medical condition was necessary; or
– Due to exceptional circumstances, you had insufficient time or opportunity to submit, (or for the TUEC to consider), your application prior to sample collection; or
– It is agreed, by WADA and by IFA, that fairness requires the grant of a retroactive TUE.

Important note:

Using a prohibited substance before being granted a TUE could result in an Adverse Analytical Finding and a potential anti-doping rule violation.

In case an application for a retroactive TUE is necessary following sample collection, you are strongly advised to have a medical file prepared and ready to submit for evaluation.


Through ADAMS or paper format / electronic TUE form

IFA encourages TUE applications using the form available in ADAMS, and submitting the required medical file through ADAMS. If you do not have an ADAMS account yet, please contact [Insert applicable contact details] to have your account set up.

Otherwise, please download the IFA’s TUE Application Form (TUE-Form) , and once duly completed and signed, send it together with the required medical file to

Your TUE application must be submitted in legible English (or French) using capital letters or typing.

The medical file includes:

– A comprehensive medical history, including documentation from the original diagnosing physician(s) (where possible);
– The results of all examinations, laboratory investigations and imaging studies relevant to the application;
– If the medical file is not in English or French, a summary explaining, in English or French, the key elements of the diagnosis, clinical examinations, medical tests and treatment plan must be provided.

Any TUE application that is not complete or legible will not be dealt with and will be returned for completion and re-submission.

To assist you and your doctor in providing the correct medical documentation, we suggest consulting the WADA’s Checklists for TUE applications for guidance and support, and Medical Information to Support the Decisions of TUECs for guidance on specific common medical conditions, treatments, substances, etc.

Keep a complete copy of the TUE application form and all medical information submitted in support of your application, and proof that it has been sent.

Your request for recognition must be submitted using the copy of your NADO’s TUE certificate, application form (in English [or French]) and supporting medical file. Please send it to

It is not necessary to translate all medical information into English [or French]. However, an English [or French] summary explaining the diagnosis and key information about medical exams, medical tests and treatment plans is required.

Any request for recognition that is not complete or legible will not be dealt with and will be returned for completion and re-submission.

Keep a complete copy of the proof that your request for recognition has been sent to IFA.

You can also simply submit your request for recognition to IFA, quoting your ADAMS NADO’s TUE reference number, if provided.

IFA’s TUEC’s decision will be communicated in writing to you within 21 days from the date of receipt of the complete TUE application [or request for recognition], including the required medical information, by IFA.

Each TUE has a specific duration, at the end of which it expires automatically. Should you need to continue to use the prohibited substance or method, it is your responsibility to submit a new application for a TUE with updated medical information ahead the expiry date, so that there is sufficient time for a decision to be made prior to the expiry of the current TUE.

Important note:
The presence (following sample collection), use, possession or administration of the prohibited substance or method shall be consistent with the terms of your TUE. Therefore, in the event that, after your TUE is granted, you require a materially different dosage, frequency, route or duration of administration, you must apply for a new TUE.
A decision to deny a TUE application includes an explanation of the reason(s) for the denial. If it is not clear to you, please contact IFA to understand exactly why the TUE was denied. Sometimes, there may be a critical piece of information, diagnostic test, laboratory results missing, etc. Failing this:

You and/or your NADO may refer the matter to WADA for review no later than 21 days after the decision was rendered by the TUEC by sending the same information that you submitted to your TUEC and on which they based their decision to deny the TUE via registered mail at:

WADA Medical Director
World Anti-Doping Agency
800 Square Victoria
Montreal, H4Z 1B7, QC

However, WADA is not obliged to proceed with such review. In that case, you and/or your NADO may appeal to the Court of Arbitration for Sport (CAS).

You and/or your NADO have 21 days to refer the matter WADA for review. You can appeal the decision by sending a registered letter together with the same information that was submitted to your TUEC and on which they based their decision not to recognize the TUE via registered mail at:

WADA Medical Director
World Anti-Doping Agency
800 Square Victoria
Montreal, H4Z 1B7, QC

Pending WADA’s decision, your NADO’s TUE remains valid for national-level competition and out-of-competition testing only.

If the matter is not referred to WADA for review, the TUE becomes invalid for any purpose when the 21-day review deadline expires.

All the information contained in a TUE application, including the supporting medical information and any other information related to the evaluation of your TUE request is kept strictly confidential and treated in accordance with the Athlete’s Declaration contained in the ADAMS TUE process. All members of the TUEC and any other authorized recipients of your TUE request and related information (as described in the Athlete’s Declaration) are subject to a professional or contractual confidentiality obligation.

Please review the terms of the Athlete’s Declaration carefully. In particular, please note that should you wish to revoke the right of the IFA’s TUEC to obtain the information related to your TUE request in accordance with the Athlete’s Declaration, your TUE application will be deemed withdrawn without approval [or recognition] being granted.

Your TUE request-related information will be retained by IFAand any other authorized recipients for no longer than necessary for the purposes stated in the Athlete’s Declaration, in accordance with the International Standard for the Protection of Privacy and Personal Information.

For any further information and questions in relation to IFA’s personal information practices, please contact Fritz Unger,

If you have a doubt as regards to which organization you should apply for a TUE, or as to the recognition process, or any other question with regard to TUEs, please contact:

WADA International Standard for Therapeutic Use Exemptions (ISTUE)
WADA Guidelines for Therapeutic Use Exemptions
WADA Q&A on Therapeutic Use Exemptions
WADA Checklists for TUE applications


customizer_element __demos

Nav Mode



Background Image

Color Skin